The webinar provides an exclusive insight into healthcare manufacturing 3D printing. Learn from the direct expertise of Michaël Vandezande, Stijn Paridaens and Anne-Sophie Grell. With their vast knowledge in prototyping as well as in mass-manufacturing via 3D printing, they will explore the challenges, opportunities, and regulations of additive manufacturing in the Healthcare sector.
The webinar below gives an exclusive insight into healthcare manufacturing 3D printing. Learn from the direct expertise of Michaël Vandezande, Stijn Paridaens and Anne-Sophie Grell.
With their vast knowledge in prototyping as well as in mass-manufacturing via 3D printing, they will take you through the challenges, opportunities, and regulations of additive manufacturing in the Healthcare sector.
向最优秀的人学习
Join us as our expert speakers share valuable insights and practical knowledge drawn from extensive industry experience.
COO at ZiggZagg
CEO at ZiggZagg
Regulatory Affairs Manager Medical Device at QbD Group
Anne-Sophie is a Regulatory Affairs leader with over two decades of experience in medical physics, diagnostic imaging, and medical device regulation. She supports clients navigating EU MDR, FDA, and international regulatory frameworks.
Keep watching
点播网络研讨会Building on QbD Group's Landing in Europe MedTech whitepaper, this webinar explains why EU market entry requires a fundamentally different approach than you might expect. We'll explore where home-market regulatory logic breaks down in Europe — with a specific focus on clinical evidence expectations, Notified Body interactions, and lifecycle obligations.
立即观看
点播网络研讨会Join our webinar to explore the essential clinical evidence needed for success, including investigations, literature reviews, technical performance, and the use of similar devices. We’ll discuss the critical role of clinical validation starting from the design phase and guide you on how to compile the necessary evidence to meet MDR requirements.
立即观看
点播网络研讨会This webinar will explore the specific requirements for various safety classifications and provide valuable insights into what Notified Bodies (NBs) and the FDA expect from your development process. Key topics will include the full development cycle, cybersecurity essentials, usability engineering, AI integration, and effective strategies for aligning agile methodologies with the strict release flows required for MDSW. Gain a deeper understanding and streamline your MDSW development process today!
立即观看专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
